Shattuck Labs, Inc.

STTK

$6.96

+0.72%

N/A+$0.05

Healthcare

Biotechnology

NASDAQ

Active Trading

Shattuck Labs, Inc. operates as a biotechnology firm based in the United States, currently at the clinical development stage. Its core mission ...

Financial Highlights of STTK

Profitability trend

Latest / TTM · 6 periods

Gross Margin

-750.9%

Net Margin

-5256.8%

P/E Ratio

-13.65x

n/a

Debt / Equity

0.01

n/a

Current Ratio

27.59

Dividend Yield

0.0%

Understanding

TTM —

Interest coverage is weak

Financial highlights

Latest / TTM · 6 periods

Snapshot

Latest / TTM: 2026-09-04

Gross Margin

-750.9%

Net Margin

-5256.8%

P/E Ratio

-13.65x

Debt / Equity

0.01

Profitability

Profitability table

Metric	2021	2022	2023	2024	2025	2026
Gross MarginGross profit as a percentage of revenue.	95.4%	-12507.2%	-143.9%	14.5%	-195.1%	—
Operating MarginOperating income as a percentage of revenue.	-150.8%	-15848.0%	-5549.6%	-1408.3%	-5150.8%	—
Net MarginNet income as a percentage of revenue.	-149.8%	-15635.7%	-5268.4%	-1318.1%	-4880.9%	—
EBITDA MarginEBITDA divided by revenue.	-145.2%	-15164.4%	-5024.5%	-1251.2%	-4512.1%	—
Pre-tax MarginPre-tax profit as a percentage of revenue.	-149.8%	-15635.7%	-5268.4%	-1318.1%	-4880.9%	—

Liquidity & leverage

Liquidity & leverage table

Metric	2021	2022	2023	2024	2025	2026
Current RatioCurrent assets divided by current liabilities.	11.72	7.39	12.51	8.88	11.70	—
Quick RatioLiquid assets divided by current liabilities.	11.72	7.39	12.51	8.88	11.70	—
Cash RatioCash and equivalents divided by current liabilities.	3.75	1.90	10.97	6.44	7.68	—
Debt / AssetsDebt as a share of total assets.	0.0%	2.4%	2.6%	3.7%	2.7%	—
Debt / EquityDebt compared with shareholder equity.	0.00	0.03	0.03	0.04	0.03	—

Operating efficiency

Operating efficiency table

Metric	2021	2022	2023	2024	2025	2026
Receivables TurnoverHow often receivables are collected in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Inventory TurnoverHow often inventory is sold in a year.	0.00x	0.00x	0.00x	0.00x	0.00x	—
Payables TurnoverHow often payables are paid in a year.	0.14x	11.46x	2.55x	2.02x	1.40x	—
Asset TurnoverRevenue generated per dollar of assets.	0.10x	0.00x	0.01x	0.06x	0.01x	—
Working Capital TurnoverRevenue generated per dollar of working capital.	0.10x	0.00x	0.01x	0.06x	0.01x	—

Valuation ratios

Valuation ratios table

Metric	2021	2022	2023	2024	2025	2026
P/E RatioPrice paid for each dollar of earnings.	-7.95x	-0.95x	-3.48x	-0.81x	-5.21x	—
P/B RatioPrice paid for each dollar of book value.	1.32x	0.55x	2.10x	0.77x	3.08x	—
P/S RatioPrice paid for each dollar of sales.	11.92x	149.50x	183.31x	10.74x	253.99x	—
P/FCF RatioPrice paid for each dollar of free cash flow.	-5.50x	-0.92x	-3.72x	-1.01x	-6.36x	—
Dividend YieldAnnual dividend divided by current share price.	0.0%	0.0%	0.0%	0.0%	0.0%	—

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer